Page 106 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors
P. 106
Chapter 6
Table 1: Overall SUVmax of healthy salivary, seromucous and lacrimal glands on PSMA PET/CT in 30 patients.
Parotid Submandibular Sublingual
Soft palate Pharyngeal wall Lacrimal glands Nasal mucosa Supraglottic larynx
N Mean SD
60 12.3 3.9 60 11.7 3.5 60 4.5 1.9 30 2.4 0.5 60 4.3 1.3 60 6.2 2.2 30 3.4 0.9 30 2.7 0.7
Range
5.2 – 22.9 6.0 – 22.2 1.2 – 8.5 1.4 – 3.6 2.5 – 7.7 2.5 – 13.6 2.2 – 5.5 1.7 – 3.8
Table 2: Intra-individual differences in SUVmax of paired salivary, seromucous and lacrimal glands on PSMA PET/CT in 30 patients.
Parotid Submandibular Sublingual Pharyngeal wall Lacrimal glands
Mean difference (% difference)
0.59 (4.9%) 0.17 (1.4%) 0.14 (3.2%) 0.04 (1.0%) 0.28 (4.6%)
SD Maximum difference (% of the mean)
1.3 3.2 (26%) 1.5 3.8 (32%) 1.1 2.6 (58%) 0.9 1.1 (26%) 0.5 2.1 (34%)
104
Figure 4: Intra-individual differences in SUVmax of paired salivary, seromucous, and lacrimal glands on PSMA PET/CT in 30 patients, showing a mean left/right difference of 9.0-18.1%. Mean (+), median, interquartile range, and range.
